New Delhi [India], October 1 (ANI): More than 2.5 lakh people have voluntarily donated blood under the Raktdaan Amrit Mahotsav, said Union Health Minister Mansukh Mandaviya on Saturday adding that it has strengthened the noble cause of humanity which will help immensely in saving many precious lives.
New Delhi [India], September 18 (ANI): Bharatiya Janata Party (BJP) President JP Nadda on Saturday, inaugurated the 'Basti Sampark Abhiyan' campaign, aiming to develop a greater connection with the people of Scheduled Castes (SC) and backward communities.
Chennai (Tamil Nadu) [India], July 5 (ANI): Researchers at Tamil Nadu's National Institute for Research in Tuberculosis (NIRT) and Indian Council of Medical Research (ICMR) found instances of reverse zoonosis (human-to-animal and animal-to-human) in the transmission of tuberculosis (TB).
Chennai (Tamil Nadu) [India], July 4 (ANI): With an aim to reduce the Tuberculosis burden in the country and eliminate the disease by 2025, the Indian Council of Medical Research (ICMR) and the National Institute for Research in Tuberculosis (NIRT) initiated a new study, informed the officials on Monday.
New Delhi [India], June 2 (ANI): The Central Government is planning to launch restructured Nikshay portal shortly to adopt Tuberculosis patients and provide them with a nutritional support system.
New Brunswick (New Jersey) [US], April 17 (ANI): According to a new study, two strains of bacteria causing tuberculosis have only minor genetic differences but attack the lungs in a completely different way.
Hyderabad Feb 24 PTI COVID-19 vaccine Covaxin maker Bharat Biotech International Limited is in the process of bringing out a vaccine against tuberculosis and soon the firm will sign a MoU with another firm for technology Our honourable Prime Minister Narendra Modi has got an agenda of 2025 for the eradication of tuberculosis I think we are in that direction But we dont have the technology so we are partnering with somebody else On that matter we should be announcing soon Krishna Ella Chairman and Managing Director Bharat Biotech in panel discussion as part of BioAsia 2022 said Without providing details on the name of the firm with which BBIL will be inking MoU Ella said the TB vaccine is currently undergoing phase 3 clinical trials He said the immunology of the nasal vaccine being developed by the company against COVID-19 has been established Bharat Biotech had last month said BBV154 Nasal vaccine received approval for phase 3 clinical trials which will evaluate the jab for both the two-dose primary schedule and booster dose schedule PTI GDK GDK SS SS
New Delhi [India], October 26 (ANI): While expressing the need to accelerate the development of new diagnostics, vaccines and drugs, use digital technology, Artificial Intelligence, and other innovations to advance TB response, Union Minister of State for Health and Family Welfare Dr Bharati Pravin Pawar on Tuesday said that 'reaching the unreached and reaching them early is a challenge'.
Chandigarh (Punjab) [India], September 29 (ANI): Punjab Governor Banwari Lal Purohit has complemented the efforts of PGIMER in maintaining the momentum of tobacco control in the country in the challenging times of the COVID19 pandemic.
New Delhi [India], September 9 (ANI): Delhi Traffic Police on Thursday advised the commuters to avoid the carriageway from TB hospital towards PTS Malviya Nagar on Aurobindo marg due to the pipe-laying work by the Delhi Jal Board (DJB).
\
\
\
\
\
\
\
\
\
\
\
\
\
\
\
\
\
\
\
\
